当前位置:首页 - 行情中心 - 复星医药(600196) - 财务分析 - 现金流量表

复星医药

(600196)

  

流通市值:484.71亿  总市值:611.44亿
流通股本:21.18亿   总股本:26.72亿

现金流量表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金42,392,553,570.1731,291,201,615.5120,988,529,284.5310,695,529,511.42
收到的税费返还441,829,818.51282,616,022.96217,771,729.1483,838,265.49
收到其他与经营活动有关的现金1,531,520,703.141,862,007,814.61,678,407,852.11,086,143,315.26
经营活动现金流入的平衡项目0000
经营活动现金流入小计44,365,904,091.8233,435,825,453.0722,884,708,865.7711,865,511,092.17
购买商品、接受劳务支付的现金17,011,031,089.2312,960,139,678.428,700,202,972.544,489,769,536.26
支付给职工以及为职工支付的现金10,603,925,695.28,032,804,716.415,491,929,374.842,842,577,879.2
支付的各项税费2,819,368,483.252,066,345,801.661,481,131,450.39778,299,147.21
支付其他与经营活动有关的现金10,517,361,760.557,914,894,769.945,401,436,933.382,881,620,493.14
经营活动现金流出的平衡项目0000
经营活动现金流出小计40,951,687,028.2330,974,184,966.4321,074,700,731.1510,992,267,055.81
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额3,414,217,063.592,461,640,486.641,810,008,134.62873,244,036.36
二、投资活动产生的现金流量:
收回投资收到的现金1,860,266,269.95971,683,442.14666,837,151.18496,377,082.92
取得投资收益收到的现金949,058,570.81888,386,091.11207,095,690.74104,941,318.8
处置固定资产、无形资产和其他长期资产收回的现金净额9,009,442.187,183,164.912,969,294.512,259,612.97
处置子公司及其他营业单位收到的现金净额300,000---
收到的其他与投资活动有关的现金934,806,317.041,260,013,178.061,560,725,322.631,119,124,084.42
投资活动现金流入的平衡项目0000
投资活动现金流入小计3,753,440,599.983,127,265,876.222,437,627,459.061,722,702,099.11
购建固定资产、无形资产和其他长期资产支付的现金5,336,704,753.144,217,498,536.442,942,563,704.961,703,104,220
投资支付的现金942,970,606.95691,319,201.85476,140,093.0484,545,733.2
取得子公司及其他营业单位支付的现金923,998,933.121,145,321,504.561,104,281,692.7747,589,200
支付其他与投资活动有关的现金369,056,679.19357,419,663.99276,668,379.4424,638,334.95
投资活动现金流出的平衡项目0000
投资活动现金流出小计7,572,730,972.46,411,558,906.844,799,653,870.211,859,877,488.15
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-3,819,290,372.42-3,284,293,030.62-2,362,026,411.15-137,175,389.04
三、筹资活动产生的现金流量:
吸收投资收到的现金76,629,839.4743,943,339.4734,315,828.4717,225,100
其中:子公司吸收少数股东投资收到的现金76,629,839.4743,943,339.4734,315,828.4717,225,100
取得借款收到的现金23,175,941,310.8118,051,361,530.0513,661,290,499.756,883,841,990.77
收到其他与筹资活动有关的现金337,726,713.85341,238,916.65275,671,350.03159,047,273.55
筹资活动现金流入平衡项目0000
筹资活动现金流入小计23,590,297,864.1318,436,543,786.1713,971,277,678.257,060,114,364.32
偿还债务支付的现金21,146,225,034.4615,547,919,509.9510,858,882,718.076,254,317,689.9
分配股利、利润或偿付利息支付的现金2,659,692,519.962,281,793,707.17781,893,132.65325,842,605.08
其中:子公司支付给少数股东的股利、利润204,522,791.93188,537,457.63156,732,640.03864,000
支付其他与筹资活动有关的现金1,120,630,108.571,003,410,173.53930,592,454.89197,982,914.89
筹资活动现金流出平衡项目0000
筹资活动现金流出小计24,926,547,662.9918,833,123,390.6512,571,368,305.616,778,143,209.87
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-1,336,249,798.86-396,579,604.481,399,909,372.64281,971,154.45
四、汇率变动对现金及现金等价物的影响73,645,025.18131,327,968.7741,414,806.15-67,365,428.91
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-1,667,678,082.51-1,087,904,179.69889,305,902.26950,674,372.86
加:期初现金及现金等价物余额11,170,066,988.5511,170,066,988.5511,170,066,988.5511,170,066,988.55
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额9,502,388,906.0410,082,162,808.8612,059,372,890.8112,120,741,361.41
补充资料:
净利润2,895,063,426.58-2,045,225,278.44-
资产减值准备351,669,556.67-149,635,297.38-
固定资产和投资性房地产折旧1,364,242,812.55-628,904,224.13-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧1,364,242,812.55-628,904,224.13-
无形资产摊销1,334,550,719.25-718,409,079.37-
长期待摊费用摊销153,493,799.99-72,672,391.56-
处置固定资产、无形资产和其他长期资产的损失-5,563,773.63--804,989.09-
固定资产报废损失5,025,297.02-2,215,660.6-
公允价值变动损失427,379,582.37--387,373,858.95-
财务费用1,169,251,842.36-523,896,255.02-
投资损失-3,501,992,600.27--1,473,380,689.52-
递延所得税-144,605,377.84-182,734,641.81-
其中:递延所得税资产减少-35,259,676.92-30,482,492.09-
递延所得税负债增加-109,345,700.92-152,252,149.72-
存货的减少-333,906,025.12--660,689,707.41-
经营性应收项目的减少1,605,091,918.04-1,020,257,257.74-
经营性应付项目的增加-2,207,773,349.94--1,150,953,455.25-
现金的期末余额9,502,388,906.04-12,059,372,890.81-
减:现金的期初余额11,170,066,988.55-11,170,066,988.55-
公告日期2024-03-272023-10-312023-08-302023-04-29
审计意见(境内)标准无保留意见
TOP↑